Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00075101 · ClinicalTrials.gov registry record · Phase 3

Sleep, Fatigue, and Dexamethosone in Children With Leukemia

A Phase 3 study, sponsored by National Institute of Nursing Research (NINR).

Completed
Registry status
Phase 3
Development phase
134
Enrollment target

NCT00075101 is a Phase 3 study that has completed, run by National Institute of Nursing Research (NINR). The registered enrollment target is 134 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00075101, a Phase 3 study, has completed, sponsored by National Institute of Nursing Research (NINR).

COMPLETED
Registry status
Phase 3
Development phase
134 participants
Enrollment target

Study Summary

The purpose of this study is to determine the relationship between dexamethosone (steroid) and children's sleep and fatigue.

Interventions

  • DRUG Dexamethosone

Trial Details

FieldValue
Enrollment Target 134 participants
Start Date 2000-09
Est. Completion 2006-09
Phase Phase 3

What the Registry Record Tells You About NCT00075101

The ClinicalTrials.gov registry entry for NCT00075101 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 134 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute of Nursing Research (NINR), which has 46 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Dexamethosone is the first listed.

NCT00075101 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00075101 about?

NCT00075101 is a clinical study titled "Sleep, Fatigue, and Dexamethosone in Children With Leukemia". The purpose of this study is to determine the relationship between dexamethosone (steroid) and children's sleep and fatigue.

What is the current status of trial NCT00075101?

This trial is currently completed. It is a Phase 3 study. The enrollment target is 134 participants. The study started on 2000-09. Estimated completion is 2006-09.

What interventions are being tested in trial NCT00075101?

The interventions under investigation include: Dexamethosone (DRUG).

Who is sponsoring clinical trial NCT00075101?

This trial is sponsored by National Institute of Nursing Research (NINR), which has 46 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.